Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24676 | 22617561 | Curr Opin Clin Nutr Metab Care | DNA methylation and hepatic insulin resistance and steatosis. | 2012 | Details |
| A24677 | 22616493 | Acta Gastroenterol Latinoam | IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome. | 2012 | Details |
| A24678 | 22615952 | PLoS One | A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. | 2012 | Details |
| A24681 | 22613376 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease]. | 2012 | Details |
| A24682 | 22612998 | J Hepatol | Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population. | 2012 | Details |
| A24683 | 22611049 | Hepatology | Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. | 2012 | Details |
| A24684 | 22611040 | Hepatology | Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. | 2012 | Details |
| A24685 | 22610995 | Obes Surg | Impact of weight-loss surgery and diabetes status on serum ALT levels. | 2012 | Details |
| A24686 | 22610002 | Clin Gastroenterol Hepatol | Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24687 | 22609320 | Eur J Radiol | Elastographic assessment of liver fibrosis in children: A prospective single center experience. | 2012 | Details |
| A24688 | 22609053 | Trends Endocrinol Metab | Role of ceramides in nonalcoholic fatty liver disease. | 2012 | Details |
| A24689 | 22606899 | Lik Sprava | [Efficiency of modern immunoactive preparation cycloferon at coplex therapy of the patients with nonalcoholic steatohepatitis combined with irritable bowel syndrome]. | 2012 | Details |
| A24690 | 22596186 | Curr Opin Cardiol | Nonalcoholic fatty liver disease and vascular risk. | 2012 | Details |
| A24691 | 22594108 | J Tradit Chin Med | Study on effects of zhi zi (fructus gardeniae) on non-alcoholic fatty liver disease in the rat. | 2012 | Details |
| A24692 | 22593713 | ScientificWorldJournal | Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease. | 2012 | Details |
| A24694 | 22589191 | Proteomics | Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet. | 2012 | Details |
| A24695 | 22588935 | Nan Fang Yi Ke Da Xue Xue Bao | [Hepatic SIRT1 and UCP2 expressions in rats with type 2 diabetes mellitus and nonalcoholic fatty liver]. | 2012 | Details |
| A24696 | 22588928 | Nan Fang Yi Ke Da Xue Xue Bao | [Efficacy of antioxidants in treatment of nonalcoholic fatty liver: a systematic review]. | 2012 | Details |
| A24697 | 22588441 | Ann Saudi Med | Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study. | 2012 | Details |
| A24698 | 22586470 | PLoS One | Hepcidin expression in iron overload diseases is variably modulated by circulating factors. | 2012 | Details |
| A24699 | 22584317 | Gan To Kagaku Ryoho | [Hepatocarcinogenesis in NASH]. | 2012 | Details |
| A24700 | 22583925 | Hepatol Res | Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study. | 2012 | Details |
| A24701 | 22583683 | Hepatol Res | Suppression of autophagy sensitizes Kupffer cells to endotoxin. | 2012 | Details |
| A24702 | 22583519 | Liver Int | The housekeeping gene YWHAZ remains stable in a model of developmentally primed non-alcoholic fatty liver disease. | 2012 | Details |
| A24703 | 22582214 | J Appl Physiol (1985) | Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A24704 | 22579612 | Mol Cell Endocrinol | The role of angiotensin II in nonalcoholic steatohepatitis. | 2012 | Details |
| A24705 | 22577564 | Int J Hepatol | Role of NKT Cells in the Pathogenesis of NAFLD. | 2012 | Details |
| A24707 | 22576780 | Diabetes Metab Res Rev | Diabetic fatty liver disease is associated with specific changes in blood-borne markers. | 2012 | Details |
| A24708 | 22576368 | Mol Med | Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A24709 | 22576023 | J Gastroenterol | Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? | 2012 | Details |
| A24710 | 22572525 | Clin Res Hepatol Gastroenterol | The relationship between copper and steatosis in Wilson's disease. | 2012 | Details |
| A24711 | 22570770 | J Nutr Metab | Health implications of high dietary omega-6 polyunsaturated Fatty acids. | 2012 | Details |
| A24712 | 22570745 | Gut Liver | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. | 2012 | Details |
| A24713 | 22570680 | Therap Adv Gastroenterol | Secondary causes of nonalcoholic fatty liver disease. | 2012 | Details |
| A24714 | 22569763 | J Gastroenterol | Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24715 | 22569330 | Lipids Health Dis | Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats. | 2012 | Details |
| A24716 | 22569299 | Life Sci | The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model. | 2012 | Details |
| A24717 | 22567408 | Int J Hepatol | Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. | 2012 | Details |
| A24718 | 22567185 | World J Hepatol | G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. | 2012 | Details |
| A24719 | 22565095 | Nat Rev Gastroenterol Hepatol | Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. | 2012 | Details |
| A24720 | 22564417 | J Diabetes | Non-alcoholic fatty liver disease. | 2012 | Details |
| A24721 | 22561871 | Toxicol Appl Pharmacol | Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. | 2012 | Details |
| A24722 | 22561686 | Nat Med | Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. | 2012 | Details |
| A24723 | 22560219 | Cell Metab | Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24724 | 22560210 | Cell Metab | Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. | 2012 | Details |
| A24726 | 22555050 | Pathophysiology | Serum paraoxonase and arylesterase activities in Iranian patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24727 | 22554516 | Biochem Biophys Res Commun | Ezetimibe reduces fatty acid quantity in liver and decreased inflammatory cell infiltration and improved NASH in medaka model. | 2012 | Details |
| A24728 | 22554494 | Brain Behav Immun | Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. | 2012 | Details |
| A24729 | 22554256 | Aliment Pharmacol Ther | Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. | 2012 | Details |
| A24730 | 22554085 | J Gastroenterol Hepatol | Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. | 2012 | Details |
| A24732 | 22551412 | J Med Food | Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. | 2012 | Details |
| A24733 | 22550592 | Int J Hepatol | Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol. | 2012 | Details |
| A24734 | 22550199 | JAMA | Diagnosis and treatment of depression in adults with comorbid medical conditions: a 52-year-old man with depression. | 2012 | Details |
| A24735 | 22546916 | Comp Med | Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs. | 2012 | Details |
| A24736 | 22546860 | J Clin Invest | The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. | 2012 | Details |
| A24737 | 22546752 | Eur J Gastroenterol Hepatol | γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. | 2012 | Details |
| A24738 | 22546610 | Clin Chim Acta | Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease. | 2012 | Details |
| A24739 | 22546554 | Nutr Metab Cardiovasc Dis | Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. | 2012 | Details |
| A24740 | 22546234 | Eur J Pharmacol | Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. | 2012 | Details |
| A24741 | 22545719 | Clin Sci (Lond) | Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. | 2012 | Details |
| A24742 | 22545359 | Pak J Biol Sci | Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. | 2012 | Details |
| A24743 | 22544914 | J Clin Endocrinol Metab | Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. | 2012 | Details |
| A24744 | 22544329 | Cell Cycle | The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. | 2012 | Details |
| A24745 | 22543623 | Eur J Nutr | A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. | 2012 | Details |
| A24746 | 22541706 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2012 | Details |
| A24747 | 22541252 | Gastroenterol Hepatol | [Influence of non-alcoholic fatty liver disease on cardiovascular disease]. | 2012 | Details |
| A24748 | 22540836 | Aliment Pharmacol Ther | Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). | 2012 | Details |
| A24749 | 22539458 | Diabetes Metab Res Rev | Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. | 2012 | Details |
| A24750 | 22538930 | Eur J Nutr | Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. | 2012 | Details |
| A24751 | 22537612 | Gastroenterology | Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. | 2012 | Details |
| A24752 | 22536512 | Int J Hepatol | Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease. | 2012 | Details |
| A24753 | 22535755 | J Nutr | Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. | 2012 | Details |
| A24754 | 22535644 | Eur J Endocrinol | Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. | 2012 | Details |
| A24755 | 22534719 | Med Sci Monit | The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania. | 2012 | Details |
| A24756 | 22532295 | Arch Pharm (Weinheim) | Synthesis and evaluation of 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of non-alcoholic fatty liver disease. | 2012 | Details |
| A24757 | 22532269 | Hepatology | Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. | 2012 | Details |
| A24758 | 22531980 | Hepatology | Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. | 2012 | Details |
| A24759 | 22531091 | Int J Obes (Lond) | Effect of intrauterine growth retardation on liver and long-term metabolic risk. | 2012 | Details |
| A24760 | 22530350 | Eur Rev Med Pharmacol Sci | Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease. | 2012 | Details |
| A24762 | 22527845 | Lipids | Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China. | 2012 | Details |
| A24763 | 22525505 | Zhonghua Gan Zang Bing Za Zhi | [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS]. | 2011 | Details |
| A24764 | 22525431 | Lab Invest | Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. | 2012 | Details |
| A24766 | 22521558 | Clin Res Hepatol Gastroenterol | Non-alcoholic fatty liver disease in children. | 2012 | Details |
| A24767 | 22521357 | J Hepatol | Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24768 | 22521354 | J Hepatol | A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. | 2012 | Details |
| A24769 | 22521350 | J Hepatol | Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24770 | 22520641 | Liver Int | Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. | 2012 | Details |
| A24771 | 22519948 | Scand J Gastroenterol | A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. | 2012 | Details |
| A24772 | 22519397 | Curr Med Chem | Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease. | 2012 | Details |
| A24774 | 22509248 | PLoS One | Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. | 2012 | Details |
| A24775 | 22509085 | World J Gastroenterol | Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24776 | 22509083 | World J Gastroenterol | Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. | 2012 | Details |
| A24777 | 22508243 | Hepatology | Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. | 2013 | Details |
| A24779 | 22505328 | Hepatology | Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. | 2012 | Details |
| A24780 | 22505276 | Hepatology | Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. | 2012 | Details |
| A24781 | 22505194 | Hepatology | Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. | 2012 | Details |
| A24782 | 22505182 | Int J Mol Med | Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24783 | 22504749 | Br J Hosp Med (Lond) | Hepatic encephalopathy. | 2012 | Details |
| A24784 | 22500386 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Clinical study of Qinggan Huatan Huoxue Recipe on the treatment of non-alcoholic steatohepatitis]. | 2012 | Details |
| A24785 | 22498245 | Best Pract Res Clin Endocrinol Metab | Metabolic insights from extreme human insulin resistance phenotypes. | 2012 | Details |